John Cogswell

Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma

Clive Taylor, Henrik Winther, Xiaoling Zhang, 2017, Applied immunohistochemistry & molecular morphology : AIMM.

IRS2 Copy Number Gain, KRAS and BRAF Mutation Status as Predictive Biomarkers for Response to the IGF-1R/IR Inhibitor BMS-754807 in Colorectal Cancer Cell Lines

Fei Huang, Dharmesh M. Patel, Han Chang, 2014, Molecular Cancer Therapeutics.

An immune-active tumor microenvironment favors clinical response to ipilimumab

Rui-Ru Ji, Nathan O. Siemers, Henrik Schmidt, 2012, Cancer Immunology, Immunotherapy.